本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kymera Therapeutics, Inc.

114.96
-2.0400-1.74%
盤前113.00-1.9600-1.70%04:15 EDT
成交量:57.42萬
成交額:6,617.17萬
市值:95.59億
市盈率:-35.79
高:119.93
開:118.40
低:113.74
收:117.00
52周最高:130.05
52周最低:45.84
股本:8,315.06萬
流通股本:6,487.46萬
量比:0.92
換手率:0.89%
股息:- -
股息率:- -
每股收益(TTM):-3.2122
每股收益(LYR):-3.6900
淨資產收益率:-24.15%
總資產收益率:-15.59%
市淨率:6.33
市盈率(LYR):-31.15

資料載入中...

2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities